Drug Discovery & Pharmaceuticals

RSS

Virginia Tech researcher receives $2.2 million to advance study on small 'fat burning' molecules

The liver is the most resilient organ in the human body. It can remove toxins from the bloodstream, recycle red blood cells, maintain sugar levels, and it can even regenerate itself. But, when a large amount of fat builds up in the liver, it becomes too inflamed to perform its crucial duties.

14 Jun 2021

UCSF launches new initiative to propel the development of living therapeutics

UC San Francisco is launching a new initiative to propel the development of living therapeutics - a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease - and bring them quickly to patients.

14 Jun 2021

Common antidepressant drugs help the immune system to attack tumors in mice

A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the brain's "happiness hormone."

10 Jun 2021

New resin acid molecules have promising properties as potential drugs against epilepsy

New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy.

8 Jun 2021

Autobahn Labs collaborates with CSHL to advance science from the lab to clinic

Autobahn Labs, an early-stage drug discovery incubator, today announced a new strategic venture collaboration with Cold Spring Harbor Laboratory.

7 Jun 2021

Rice scientist wins NIH grant to model and analyze protein-ligand interactions in cancer research

Computer scientist Lydia Kavraki of Rice University's Brown School of Engineering has won a prestigious National Institutes of Health U01 grant to develop a new approach to model and analyze protein-ligand interactions in cancer research.

7 Jun 2021

Research opens alternative therapeutic avenues for treatment of chronic pain

Building on previous findings, scientists have demonstrated that conolidine interacts with the newly identified opioid receptor ACKR3/CXCR7.

3 Jun 2021

Scientists identify many existing drugs with antiviral activity against coronavirus

Mining the world's most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that's driving the ongoing global pandemic.

3 Jun 2021

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

Restek’s new cannabinoid 9-component mix streamlines cannabinoid analyses.

From Restek Corporation 3 Jun 2021

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

A recent Science paper discusses the utilization of a previously reported synthetic Escherichia coli to produce virus-resistant synthetic polymers.

3 Jun 2021

NUS researchers develop a way to automate the production of pharmaceutical small molecules

The discovery and development of new small-molecule compounds for therapeutic use involves a huge investment of time, effort and resources.

1 Jun 2021

Students isolate 570 microbes from soil samples to identify new antibiotics

The 57 Valencian students who have taken part in the "En busca de nuevos Fleming" (Searching for the new Fleming) project of the SWICEU team, have showcased their results in an event held at the assembly room of the CEU Cardenal Herrera university.

17 May 2021

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome.

14 May 2021

New peptide could allow cannabis to fight pain without side effects

Many people live with chronic pain, and in some cases, cannabis can provide relief. But the drug also can significantly impact memory and other cognitive functions.

12 May 2021

New drug-like compound could effectively block a critical step in malaria parasite life cycle

Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential first of its kind malaria treatment.

12 May 2021

Drug Discovery & Pharmaceuticals

Virginia Tech researcher receives $2.2 million to advance study on small 'fat burning' molecules

UCSF launches new initiative to propel the development of living therapeutics

Common antidepressant drugs help the immune system to attack tumors in mice

New resin acid molecules have promising properties as potential drugs against epilepsy

Autobahn Labs collaborates with CSHL to advance science from the lab to clinic

Rice scientist wins NIH grant to model and analyze protein-ligand interactions in cancer research

Research opens alternative therapeutic avenues for treatment of chronic pain

Scientists identify many existing drugs with antiviral activity against coronavirus

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

NUS researchers develop a way to automate the production of pharmaceutical small molecules

Students isolate 570 microbes from soil samples to identify new antibiotics

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

New peptide could allow cannabis to fight pain without side effects

New drug-like compound could effectively block a critical step in malaria parasite life cycle

Researchers develop a hairpin-shaped bicyclic peptide to fight cancer

Low dose of a four-drug combination helps prevent cancer metastasis in mice

New approach targeting viral RNA could lead to broad spectrum anti-viral drugs

Researchers reach new milestone in the development of effective malaria vaccine

New combination treatment could benefit T-ALL patients who do not respond to chemotherapy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest Life Science News